ChengDu ShengNuo BiotecLtd 미래 성장
Future 기준 확인 5/6
ChengDu ShengNuo BiotecLtd is forecast to grow earnings and revenue by 33.8% and 27.7% per annum respectively. EPS is expected to grow by 33.6% per annum. Return on equity is forecast to be 15.6% in 3 years.
주요 정보
33.8%
수익 성장률
33.6%
EPS 성장률
| Pharmaceuticals 수익 성장 | 19.3% |
| 매출 성장률 | 27.7% |
| 향후 자기자본 수익률 | 15.6% |
| 애널리스트 커버리지 | Low |
| 마지막 업데이트 | 06 Aug 2024 |
최근 미래 성장 업데이트
업데이트 없음
Recent updates
ChengDu ShengNuo BiotecLtd (SHSE:688117) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Nov 04
ChengDu ShengNuo Biotec Co.,Ltd. (SHSE:688117) Stocks Shoot Up 32% But Its P/E Still Looks Reasonable
Aug 26A Look At The Fair Value Of ChengDu ShengNuo Biotec Co.,Ltd. (SHSE:688117)
Jun 19ChengDu ShengNuo BiotecLtd (SHSE:688117) Strong Profits May Be Masking Some Underlying Issues
Apr 29There's Reason For Concern Over ChengDu ShengNuo Biotec Co.,Ltd.'s (SHSE:688117) Massive 27% Price Jump
Mar 04수익 및 매출 성장 예측
| 날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
|---|---|---|---|---|---|
| 12/31/2026 | 893 | 200 | N/A | 230 | 1 |
| 12/31/2025 | 679 | 153 | N/A | 211 | 1 |
| 12/31/2024 | 530 | 109 | N/A | 129 | 1 |
| 9/30/2024 | 482 | 92 | -171 | 81 | N/A |
| 6/30/2024 | 460 | 72 | -220 | 94 | N/A |
| 3/31/2024 | 458 | 73 | -221 | 80 | N/A |
| 12/31/2023 | 435 | 70 | -193 | 85 | N/A |
| 9/30/2023 | 427 | 60 | -188 | 89 | N/A |
| 6/30/2023 | 402 | 66 | -118 | 82 | N/A |
| 3/31/2023 | 396 | 64 | -85 | 83 | N/A |
| 12/31/2022 | 396 | 64 | -40 | 96 | N/A |
| 9/30/2022 | 368 | 57 | -6 | 61 | N/A |
| 6/30/2022 | 360 | 56 | 2 | 72 | N/A |
| 3/31/2022 | 374 | 64 | -2 | 57 | N/A |
| 12/31/2021 | 387 | 61 | -12 | 52 | N/A |
| 9/30/2021 | 387 | 61 | -18 | 48 | N/A |
| 6/30/2021 | 397 | 53 | -8 | 44 | N/A |
| 3/31/2021 | 401 | 62 | 15 | 78 | N/A |
| 12/31/2020 | 379 | 60 | 29 | 81 | N/A |
| 12/31/2019 | 327 | 48 | 0 | 31 | N/A |
| 12/31/2018 | 278 | 30 | 35 | 66 | N/A |
| 12/31/2017 | 194 | 34 | N/A | 58 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: 688117's forecast earnings growth (33.8% per year) is above the savings rate (2.9%).
수익 vs 시장: 688117's earnings (33.8% per year) are forecast to grow faster than the CN market (25.8% per year).
고성장 수익: 688117's earnings are expected to grow significantly over the next 3 years.
수익 대 시장: 688117's revenue (27.7% per year) is forecast to grow faster than the CN market (14% per year).
고성장 수익: 688117's revenue (27.7% per year) is forecast to grow faster than 20% per year.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: 688117's Return on Equity is forecast to be low in 3 years time (15.6%).